VUDALIMAB for Adenocarcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 18 adverse event reports in the FDA FAERS database where VUDALIMAB was used for Adenocarcinoma.
Most Reported Side Effects for VUDALIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Anaemia | 21 | 31.8% | 3 | 19 |
| C-reactive protein increased | 20 | 30.3% | 7 | 20 |
| Pyrexia | 18 | 27.3% | 0 | 16 |
| Malignant neoplasm progression | 13 | 19.7% | 5 | 11 |
| Pneumonia | 13 | 19.7% | 2 | 13 |
| Dyspnoea | 12 | 18.2% | 1 | 11 |
| Nausea | 12 | 18.2% | 6 | 11 |
| Platelet count decreased | 12 | 18.2% | 1 | 10 |
| Hypoxia | 10 | 15.2% | 2 | 10 |
| Vomiting | 10 | 15.2% | 0 | 10 |
| Abdominal pain | 9 | 13.6% | 7 | 9 |
| Asthenia | 9 | 13.6% | 0 | 8 |
| Fatigue | 9 | 13.6% | 1 | 6 |
| Hypotension | 9 | 13.6% | 1 | 9 |
| Blood creatinine increased | 8 | 12.1% | 0 | 8 |
Other Indications for VUDALIMAB
Other Drugs Used for Adenocarcinoma
OXALIPLATIN (646)
CARBOPLATIN (581)
FLUOROURACIL (548)
PACLITAXEL (398)
PEMBROLIZUMAB (384)
PEMETREXED (374)
DOCETAXEL (350)
BEVACIZUMAB (338)
CAPECITABINE (338)
NIVOLUMAB (304)